Drawing for RESTANVIA

USPTO serial 87311918

RESTANVIA

Reviewed by CopyMark Law Group

Status 605
Filing date
Status date
Registration date
—
Examiner
AIKENS, RONALD E
Law office
GENERIC WEB UPDATE

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with RESTANVIA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Kristina Bieker-Brady

KRISTINA BIEKER-BRADY CLARK & ELBING LLP101 FEDERAL STREET, 15TH FLOORBOSTON, MA 02110UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical products for the treatment of inflammatory and fibrotic diseasesABANDONED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 1, 2017MAB5ABANDONMENT NOTICE MAILED - AFTER PUBLICATION—
Aug 1, 2017ABN5ABANDONMENT - AFTER PUBLICATION—
Jul 27, 2017EXARTEAS EXPRESS ABANDONMENT RECEIVED—
Jun 15, 2017ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
May 30, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 30, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 10, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 19, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 19, 2017DOCKASSIGNED TO EXAMINER—
Jan 28, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—

Frequently asked questions

Related guidance